Meridian’s Merilas 810 short-pulse laser treats retina and glaucoma, including advanced and end-stage glaucoma.
Offering transscleral cyclophotocoagulation (TSCPC), the Merilas 810 has been shown to safely reduce intraocular pressure in patients where previous medications and treatments were not effective.
The Merilas 810’s unique thermal-electrical cooling system ensures quiet operation and, because it doesn’t need ventilation slots, dust can’t penetrate the interior of the laser, which improves longevity and reliability. Meridian has been developing, manufacturing, and maintaining ophthalmic lasers for more than 35 years and Device Technologies is the exclusive distributor of the Meridian laser range in Australia and New Zealand.
Contact: Device Technologies (AUS) 1300 338 423
